Ningbo Newbay Technology Development Co., Ltd
3 clinical trials · Sponsor
◉ Watch Ningbo Newbay Technology Development Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT07379047) | Ningbo Newbay Technology Development Co., Ltd | 2026-05-11 |
| A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors (NCT05036291) | Ningbo Newbay Technology Development Co., Ltd | 2021-10-01 |
Track Ningbo Newbay Technology Development Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.